Jump to content

User talk:Alternative account no2012

Page contents not supported in other languages.
From Wikipedia, the free encyclopedia

This is an old revision of this page, as edited by Alternative account no2012 (talk | contribs) at 06:25, 16 February 2012. The present address (URL) is a permanent link to this revision, which may differ significantly from the current revision.


I've deleted primary drug resistance under the speedy-deletion criteria as a blatant copyright violation. As best I can tell, most or all of the article consisted of verbatim excerpts from various published papers. Please don't do that; it's a serious violation of this site's policies. You can take a look at the copyright policy or m:Terms of use for more information. MastCell Talk 21:49, 13 February 2012 (UTC)[reply]

Nonsense. A copyvio must be 2,500 words or longer to be unlawful. Short statements cannot be normally be copyrighted. The “unambiguous copyright infringement” exists only in your imagination. Moreover, it is not possible to revise any real or imagined problems with the edits, since you have deleted all of them. --Alternative account no2012 (talk) 22:35, 13 February 2012 (UTC)[reply]
Actually, your edits were plagiarism, as defined in the third box here ("Copying from a source acknowledged in a well-placed citation, without in-text attribution"). But it was also a copyright violation, according to my understanding of this site's copyright policies. I'm not familiar with a 2,500-word cutoff; perhaps you could elaborate? Surely you're not suggesting that one can copy and paste up to 2,499 words from a copyrighted source with impunity?

In any case, if you think I've acted wrongly, I'd be happy to submit this case for wider discussion. Alternately, you are free to re-write an article on primary drug resistance (or, probably more appropriately, add a section to drug resistance), but in doing so you need to respect this site's copyright policies, or your account will be blocked. MastCell Talk 23:07, 13 February 2012 (UTC)[reply]